Roy, ‘Capitalizing a Cure: How Finance Controls the Price and Value of Medicines’

Abstract Capitalizing a Cure takes readers into the struggle over a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When curative treatments for hepatitis C launched in 2013, sticker shock over their prices intensified the global debate over access to new medicines. Weaving historical research with insights from political […]

Continue Reading

Private Equity has sabotaged every attempt to end emergency room “surprise billing”

Originally published at pluralistic.net Cory Doctorow “Surprise billing” is when you go to the ER and discover that the doc, the specialist, or the test you got were performed by “independent contractors” who are not part of the hospital’s deal with your insurer. It means bills for thousands (literally) for an ice-pack. https://www.healthexec.com/topics/healthcare-economics/5751-ice-pack-hefty-bills-await-patients-just-walking-er The surprise […]

Continue Reading